Company: ATHE
Filing Date: 2025-08-29
Form Type: 20-F
Source: 0001213900-25-082027
Chunk: 98

Company: ALTERITY THERAPEUTICS LTD
Filing Date: 2025-08-29
Form: 20-F
Item: Item 7
Chunk 98
---
ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS

A.   Major Shareholders
-----------------------

There are no shareholders known to us who own beneficially more than 5% of our ordinary shares.

Significant Changes in the Ownership of Major Shareholders

JPMorgan Chase & Co. reported on Schedule 13G filed on May 2, 2025, that it was the beneficial owner of 429,671,484 Ordinary Shares, representing approximately 6.3% of our outstanding Ordinary Shares. On May 5, 2025, JPMorgan Chase & Co. reported that it was the beneficial owner of 366,034,937 Ordinary Shares, representing approximately 4.0% of our outstanding Ordinary Shares.
Major Shareholders Voting Rights

A major shareholder would not have different voting rights.

Record Holders

As of August 22, 2025, there were 5,851 holders of record of our ordinary shares, of which 24 record holders, holding approximately 35.33% of our ordinary shares, had registered addresses in the United States. These numbers are not representative of the number of beneficial holders of our shares nor are they representative of where such beneficial holders reside, since many of these ordinary shares were held of record by brokers or other nominees. The majority of trading by our U.S. investors is done by means of ADSs that are held of record by HSBC Custody Nominees Ltd., which held 35.1% of our ordinary shares.

B.   Related Party Transactions
-------------------------------

Several of the Directors participated in the placement in April 2025. These placement shares were at arm’s length and purchased for cash. There were no other related party transactions other than those related to Director and Key Management Personnel remuneration.

C.   Interests of Experts and Counsel
-------------------------------------

Not applicable.

61